Japan Hospice Holdings Inc. (7061) AI Stock Analysis

• Market Cap: ¥6.14B
• Dividend Yield: 1.41%
• Average Volume (3M): 47.89K
• Price to Earnings (P/E): 33.9
• Beta (1Y): 1.19
• Revenue Growth: 18.03%
• EPS Growth: -11.68%
• Country: JP
• Employees: 1,094
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -3.16
• Shares Outstanding: 8,428,100
• 10 Day Avg. Volume: 91,680
• 30 Day Avg. Volume: 47,890
• PEG Ratio: -0.59
• Price to Book (P/B): 2.56
• Price to Sales (P/S): 0.66
• P/FCF Ratio: -7.11
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 199.5
• Revenue Forecast (FY): ¥20.00B

• Rating: 45 Neutral
• Price Target: ¥710.00 ▼(-36.61% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is held back primarily by weakening profitability, high leverage, and persistently negative free cash flow, which together increase financial risk. Technicals add further pressure as the stock remains in a pronounced downtrend with negative momentum, while valuation is only modestly supportive due to a relatively high P/E offset by a mid-single-digit dividend yield.

Positive Factors

Consistent revenue growth

Sustained top-line growth through 2025 shows the company is expanding service penetration and maintaining demand for hospice and palliative care. Stable revenue growth provides a durable base for operational planning and supports long-term business viability despite margin pressure.

Negative Factors

High leverage

A debt-to-equity ratio near 3.6x materially limits financial flexibility and raises refinancing and interest coverage risk. High leverage constrains capital allocation, increases vulnerability to adverse revenue or margin shocks, and makes sustained investment or deleveraging harder without improved cash generation.

Japan Hospice Holdings Inc. Business Overview & Revenue Model

Company Description

Japan Hospice Holdings Inc. engages in hospice housing and home care businesses in Japan. The company offers care services at hospice housing for patients with terminal cancer and intractable diseases; and home-visit nursing services. It also prov...

Read more

Japan Hospice Holdings Inc. engages in hospice housing and home care businesses in Japan. The company offers care services at hospice housing for patients with terminal cancer and intractable diseases; and home-visit nursing services. It also prov...

How the Company Makes Money

The company primarily earns revenue by delivering hospice and palliative care services that are reimbursed under Japan’s healthcare and long-term care insurance systems. Key revenue streams include (1) fees from medical services provided to patien...

Read more

The company primarily earns revenue by delivering hospice and palliative care services that are reimbursed under Japan’s healthcare and long-term care insurance systems. Key revenue streams include (1) fees from medical services provided to patien...

Japan Hospice Holdings Inc. Financial Statement Overview

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	13.13B	14.17B	12.12B	9.87B	7.89B	6.02B
Gross Profit	1.97B	1.84B	2.11B	1.92B	1.58B	1.12B
EBITDA	1.76B	1.43B	1.82B	1.79B	1.40B	852.01M
Net Income	529.62M	278.01M	639.58M	681.88M	454.73M	240.80M
Balance Sheet
Total Assets	17.98B	18.92B	18.31B	15.16B	11.45B	9.15B
Cash, Cash Equivalents and Short-Term Investments	1.40B	2.01B	1.53B	1.88B	1.51B	1.04B
Total Debt	12.70B	13.18B	13.19B	10.89B	8.09B	6.67B
Total Liabilities	14.47B	15.25B	14.86B	12.47B	9.41B	7.61B
Stockholders Equity	3.52B	3.68B	3.45B	2.69B	2.01B	1.54B
Cash Flow
Free Cash Flow	0.00	-1.32B	-2.27B	-865.26M	340.76M	-1.45B
Operating Cash Flow	0.00	1.05B	835.74M	1.13B	873.83M	467.10M
Investing Cash Flow	0.00	-511.73M	-2.79B	-1.01B	48.27M	-1.98B
Financing Cash Flow	0.00	-47.03M	1.60B	256.45M	-448.16M	1.59B

Japan Hospice Holdings Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1120.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7061, the sentiment is Negative. The current price of 1120 is above the 20-day moving average (MA) of 825.95, above the 50-day MA of 955.98, and below the 200-day MA of 1136.00, indicating a bearish trend. The MACD of -57.59 indicates Positive momentum. The RSI at 26.97 is Positive, neither overbought nor oversold. The STOCH value of 13.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7061.

Japan Hospice Holdings Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2425	74 Outperform	¥2.98B	27.02	―	2.56%	-3.06%	-38.56%
6062	72 Outperform	¥40.76B	11.61	―	2.63%	0.30%	-31.28%
7071	62 Neutral	¥41.00B	10.69	―	0.91%	15.77%	-50.57%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
2373	51 Neutral	¥5.72B	23.20	―	4.07%	6.08%	38.00%
7061	45 Neutral	¥6.14B	33.86	―	1.41%	18.03%	-11.68%